...
首页> 外文期刊>Tropical Journal of Pharmaceutical Research >Cardioprotective effect of salvianolic acid B against isoproterenol-induced inflammation and histological changes in a cardiotoxicity rat model
【24h】

Cardioprotective effect of salvianolic acid B against isoproterenol-induced inflammation and histological changes in a cardiotoxicity rat model

机译:丹酚酸B对异丙肾上腺素诱发的炎症和心脏毒性大鼠模型的组织学变化的心脏保护作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose: To investigate the cardioprotective role of salvianolic acid B (SAB-B) against isoproterenol (ISO)-induced cardiotoxicity in a rat model. Methods: A total of 32 male rats were equally divided into four groups as follows: control group given saline only; rats treated with ISO (85 mg/kg; i.p.) for 2 consecutive days (MI model; ISO group); rats pre-treated with SAB-B (20 mg/kg, i.p.) prior to exposure to ISO (SAB-B+ISO, treatment group), and rats administrated SAB-B (20 mg/kg, i.p.) for 28 days (SAB-B group). Results: Pre-treatment with SAB-B for 28 days enhanced the levels of various antioxidants (CAT, SOD and GSH) and hemodynamic parameters, viz, systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP). Likewise, substantial decrease in the levels of lipid peroxidation product (MDA), inflammatory markers (NF-κb, TNF-α, IL-1β and IL-6), heart weight, heart-to-body weight ratio, and serum cardiac markers (CPK and LDH) were seen in SAB-B treated rats, relative to ISO-treated group. Rats in SAB-B group had significantly downregulated protein ex pressions of NF-κb and TNF-α, and significant reduction in histopathological changes (edema and necrosis) after 28 days of treatment. Conclusion: SAB-B possesses potent cardio-protective potential against ISO-induced cardiotoxicity due to its antioxidant, anti-inflammatory and anti-necrotic properties.
机译:目的:研究丹酚酸B(SAB-B)对异丙肾上腺素(ISO)诱导的大鼠心脏毒性的心脏保护作用。方法:将32只雄性大鼠平均分为四组。连续2天用ISO(85 mg / kg;腹膜内)治疗的大鼠(MI模型; ISO组);在暴露于ISO(SAB-B + ISO,治疗组)之前用SAB-B(20 mg / kg,ip)预处理的大鼠,以及连续28天服用SAB-B(20 mg / kg,ip)的大鼠( SAB-B组)。结果:用SAB-B预处理28天可提高各种抗氧化剂(CAT,SOD和GSH)的水平以及血液动力学参数,即收缩压(SBP),舒张压(DBP)和平均动脉压(MAP) )。同样,脂质过氧化产物(MDA),炎性标志物(NF-κb,TNF-α,IL-1β和IL-6),心脏重量,心脏与体重的比率以及血清心脏标志物的水平显着下降相对于ISO治疗组,在SAB-B治疗的大鼠中观察到了CPK和LDH。治疗28天后,SAB-B组大鼠的NF-κb和TNF-α蛋白表达显着下调,组织病理学改变(水肿和坏死)显着减少。结论:SAB-B具有抗氧化,抗炎和抗坏死的特性,因此具有抗ISO诱导的心脏毒性的强大心脏保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号